December 5, 2019

GE Healthcare Life Sciences to Expand KUBio Through Close Collaboration with Pharmadule Morimatsu


GE Healthcare Life Sciences has announced it will be working closely with Pharmadule Morimatsu to expand its KUBio “factory in a box” so that biopharma manufacturers will be able to quickly scale up vaccines, viral vector-based therapies, and other novel modalities.

Click here to read more.

Tags: scale-up, vaccines, viral vector